Get started
Author

Paola Piccolo

C-reactive protein is increased in patients with degenerative aortic valvular stenosis
2001 · Alberto Galante, Antonio Pietroiusti, et al. · Journal of the American College of Cardiology · 206
PDF
A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B
2009 · Paola Piccolo, Ilaria Lenci, et al. · Antiviral Therapy · 88
Low-dose Hepatitis B Immunoglobulin Given “on Demand” in Combination With Lamivudine: a Highly Cost-effective Approach to Prevent Recurrent Hepatitis B Virus Infection in the Long-term Follow-up After Liver Transplantation
2004 · Daniele Di Paolo, Giuseppe Tisone, et al. · Transplantation · 55
Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients
2021 · Gianpiero D’Offizi, Chiara Agrati, et al. · Liver International · 41
PDF
Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant
2007 · Claudia Telesca, Mario Angelico, et al. · Journal of Infection · 38
Hepatitis C Virus and Human Immunodeficiency Virus-1 Co-Infection in Former Heroin Addicts in Methadone Maintenance Treatment
2002 · Paola Piccolo, Lisa Borg, et al. · Journal of Addictive Diseases · 33
Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co‐infection with silent hepatitis B
2008 · Gavin Bart, Paola Piccolo, et al. · Addiction · 25
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post‐transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study
2017 · Raffaella Lionetti, Vincenza Calvaruso, et al. · Clinical Transplantation · 24
Leukocyte Count and Aggregation during the Evolution of Cerebral Ischemic Injury
1998 · Mauro Silvestrini, Antonio Pietroiusti, et al. · Cerebrovascular Diseases · 21
A Randomized Controlled Trial of Sequential Pegylated Interferon-α and Telbivudine or Vice Versa for 48 Weeks in Hepatitis B E Antigen-Negative Chronic Hepatitis B
2012 · Paola Piccolo, Ilaria Lenci, et al. · Antiviral Therapy · 18
PDF
“Real world” efficacy of bulevirtide in HBV / HDV ‐related cirrhosis including people living with HIV : Results from the compassionate use programme at INMI Spallanzani in Rome, Italy
2023 · Ubaldo Visco Comandini, Emanuela De Santis, et al. · HIV Medicine · 17
PDF
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study
2009 · P. Piccolo, I. Lenci, et al. · European Journal of Public Health · 14
Leucocyte Rheological Properties Are Altered in Patients with Diffuse Atherosclerosis
1997 · Alberto Galante, Antonio Pietroiusti, et al. · Thrombosis and Haemostasis · 14
Peginterferon ??-2a and ribavirin versus peginterferon ??-2a monotherapy in early virological responders and peginterferon ??-2a and ribavirin versus peginterferon ??-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in na??ve patients with chronic hepatitis C
2008 · Mario Angelico, Beate Koehler-Horst, et al. · European Journal of Gastroenterology & Hepatology · 11
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study
2019 · Raffaella Lionetti, Paola Piccolo, et al. · Annals of Hepatology · 9
PDF
Infection with Helicobacter pylori and Leukocyte Response in Patients with Myocardial Infarction
2000 · A. Galante, A. Pietroiusti, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 8
Treating chronic hepatitis C in recovering opiate addicts: yes, we can
2009 · M.J. Kreek, A.H. Talal, et al. · Digestive and Liver Disease · 6
Severe drug induced acute hepatitis associated with use of St John’s wort (Hypericum perforatum) during treatment with pegylated interferon α
2009 · Paola Piccolo, Silvia Gentile, et al. · BMJ Case Reports · 6
[54] PEGINTERFERON-ALPHA-2a PLUS ADEFOVIR VS. PEGINTERFERON ALPHA-2a FOR 48 WEEKS IN HBeAg-NEGATIVE CHRONIC HEPATITIS B: PRELIMINARY 24-WEEK RESULTS OF THE PEG FOR B RANDOMIZED MULTICENTER TRIAL
2007 · P. Piccolo, I. Lend, et al. · Journal of Hepatology · 6
PDF
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial
2013 · Simona Francioso, Cristiana Almerighi, et al. · Digestive and Liver Disease · 5
Recurrent myocardial ischaemia during combination antiviral therapy in a patient with chronic hepatitis C and normal aminotransferase levels
2007 · I. Lenci, P. Piccolo, et al. · Digestive and Liver Disease · 5
256 Peginterferon Alpha-2a Plus Adefovir Dipivoxil vs. Peginterferon Alpha-2a Monotherapy for 48 Weeks in HBeAg-Negative Chronic Hepatitis B: Final Results of the PEG for B Randomized Multicenter Trial
2008 · Paola Piccolo, Luigi De Melia, et al. · Gastroenterology · 4
Real-world use of remdesivir for the treatment of patients admitted to Italian hospitals with COVID-19: the nationwide retrospective FADOI-RECOVER study
2023 · Filippo Pieralli, Fulvio Pomero, et al. · BMC Infectious Diseases · 3
PDF
Amantadine for treatment of hepatitis C: Time to say “enough is enough”?
2010 · Paola Piccolo · Digestive and Liver Disease · 3
Third dose of SARS‐CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients
2023 · Marzia Montalbano, Paola Piccolo, et al. · Liver International · 2
PDF
Works count: 48
Citation count: 672
H-index: 13
I10-index: 14
Year
Topic
Type